Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 11/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.53 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.53 |
| ▸ | MME | P08473 | 1/20 | 0.51 |
| ▸ | ACE | P12821 | 1/20 | 0.51 |
| ▸ | CPA1 | P15085 | 1/20 | 0.51 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.51 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | YARS1 | P54577 | 2/20 | 0.49 |
| ▸ | ANPEP | P15144 | 1/20 | 0.48 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9822681 | 0.95 | ACE (0.55) | OPRD1OPRM1OPRK1MMEACE | |
| SCHEMBL11799017 | 0.95 | ACE (0.55) | OPRD1OPRM1OPRK1MMEACE | |
| SCHEMBL9822685 | 0.95 | ACE (0.55) | OPRD1OPRM1OPRK1MMEACE | |
| SCHEMBL30714772 | 0.94 | OPRD1 (0.49) | OPRD1OPRM1OPRK1MMEACE | |
| SCHEMBL30974364 | 0.91 | CTSD (0.54) | OPRD1OPRM1OPRK1MMEACE | |
| SCHEMBL29720334 | 0.90 | CTSD (0.53) | OPRD1OPRM1OPRK1MMEACE | |
| SCHEMBL30051265 | 0.90 | CTSD (0.53) | OPRD1OPRM1OPRK1MMEACE | |
| SCHEMBL29822653 | 0.89 | ACE (0.59) | OPRD1OPRM1OPRK1MMEACE | |
| SCHEMBL30714773 | 0.89 | BACE1 (0.53) | OPRD1OPRM1OPRK1MMEACE | |
| SCHEMBL31265324 | 0.89 | OPRD1 (0.56) | OPRD1OPRM1OPRK1SLC7A5YARS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11826423-B2 | Nucleic acids for treatment of allergies | IMMUNOMIC THERAPEUTICS, INC. (US) | 2023-11-28 | — | — | US | disclosed |